Sun Pharmaceutical Industries Ltd. 524715 -1.28% shares inched down 0.54% to 1,798.05 Indian rupees Tuesday, on what proved ...

Get the latest Sun Pharmaceutical Industries share price on NSE & BSE. Explore Sun Pharma’s stock performance, quarterly earnings, R&D updates, and financial statements from India’s leading ...

Novo Nordisk Sun Pharma The approval marks a major win for Sun Pharma in its patent dispute with Danish drugmaker Novo Nordisk, the company that manufactures weight loss drug Ozempic ...

The Delhi High Court has allowed Sun Pharma to manufacture and export semaglutide-based drugs to countries where Novo Nordisk ...

Overview Neuland Labs leads the pack with an outstanding 5-year CAGR of 74.3%, supported by strong earnings and efficient ...

The court, however, permitted Sun Pharma to manufacture and export semaglutide to non-patent countries, extending the same relief it granted Dr. Reddy’s Laboratories in a similar dispute earlier this ...

Earlier, the court had declined Novo’s plea for an interim injunction against Dr Reddy’s Labs and permitted the company to ...

The Delhi High Court has allowed Sun Pharmaceutical Industries Ltd. to manufacture and export its semaglutide-based drug, ...

Sun Pharma concludes National B-school Competition SUN PRISM 2025: Our Bureau, Mumbai Thursday, December 11, 2025, 16:30 Hrs [IST] Sun Pharmaceutical Industries Limited, India’s ...

From generics to branded drugs, Jefferies’ latest pharma calls spotlight Alkem, Lupin, Sun Pharma, Torrent, and Zydus as India’s key growth stories.

Sun Pharmaceutical Industries has announced the launch of its global innovative drug, Ilumya (tildrakizumab) in India for ...